Concepedia

Domenica Rubino

DR

37

Publications

6.7K

Citations

26

H-Index

1995

Active since

Affiliations

Washington Center for Weight Management and Research(Current)

Novo Nordisk (Denmark)

University of Pennsylvania

University of Alabama at Birmingham

NIHR Leicester Biomedical Research Centre

Domenica Rubino is an author at Washington Center for Weight Management and Research specializing in medicine, obesity, and diabetes.

ORCID

Top concepts

Publications per year

1995–2025

37

Publications

37

Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity

Domenica Rubino, Niclas Abrahamsson, Melanie J. Davies et al. · JAMA · 2021 · 1.1K citations · Full text

Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity

Thomas A. Wadden, Timothy S. Bailey, Liana K. Billings et al. · JAMA · 2021 · 908 citations · Full text

3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

Carel W. le Roux, Arne Astrup, Ken Fujioka et al. · The Lancet · 2017 · 813 citations

, , +8

A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity‐related risk factors (COR‐II)

Caroline M. Apovian, Louis J. Aronne, Domenica Rubino et al. · Obesity · 2013 · 688 citations · Full text

Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial

Filip K. Knop, Vanita R. Aroda, Ruben D do Vale et al. · The Lancet · 2023 · 329 citations

, , +6

Rows per page

1–5 of 37